echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Hypertension: Uric acid, blood pressure and cardiovascular disease

    Hypertension: Uric acid, blood pressure and cardiovascular disease

    • Last Update: 2021-01-18
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Serum uric acid has been explicitly associated with hypertension and cardiovascular disease, but it is not clear whether there is a causal relationship between hypertension and cardiovascular disease.
    To clarify the problem, researchers used data from the British Biolibrary, the Millionaire Project and the Genome Association Research Consortium to conduct a randomized analysis of Mendel and a meta-analysis of randomized controlled trials in a recent study published in hypertension, an authoritative journal of cardiovascular disease.
    the main randomized analysis of Mendel showed that every SD increase in serum uric acid predicted by the gene increased coronary heart disease (ratio ratio of 1.19 (95% CI is 1.10-1.30) ;P×10-5), and exosorcical artery disease (1.11). 2 risk of stroke (1.11×% CI is 1.05-1.18) and stroke (95% CI is 1.05-1.18) ;P ;P×10-4).
    mendel randomized mediated analysis, it was estimated that elevated blood pressure could mediate the effects of uric acid on cardiovascular disease risk by about one-third.
    evaluation and meta-analysis of randomized controlled trials showed that ureatic acid therapy in patients with cardiovascular disease had a systolic blood pressure reduction (average difference of -2.55 mmHg (95% CI is -4.06 to -1.05) ;P×10-3) and major adverse cardiovascular events (ratio of 0.40). (95% CI is 0.22-0.73) ;P×10-3) has a protective effect, but there is no significant effect on the major cardiovascular adverse events in all individuals (the ratio ratio is 0.67 (95% CI is 0.44-1.03) ;P is 0.07).
    , these Mendel randomized and clinical trial data support higher levels of serum uric acid with the effect of higher blood pressure, which may mediate the risk of cardiovascular disease.
    high-quality trials are required to provide definitive evidence of the cardiovascular benefit of reducing uric acid.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.
    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent Echemi's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.